Skip to content
JAMA Dermatology Author Interviews cover art

All episodes

JAMA Dermatology Author Interviews, 132 episodes. Page 2 of 2.

#
Title
101

Variation in the Cost of Managing Actinic Keratosis

102

Diversity of Trial Participants in Dermatology Clinical Trials

103

Method of Prescribing and Primary Nonadherence to Dermatologic Medication

104

Exploring the Industry-Dermatologist Financial Relationship

105

Sterile vs Nonsterile Gloves in Surgery and Outpatient Procedures

106

Patient Preferences in Dermatologist Attire

107

Red Hair, Light Skin, and UV-Independent Risk for Melanoma

108

Point-of-Care Treatment Decisions for Hidradenitis Suppurativa

109

Laboratory Monitoring During Isotretinoin Therapy for Acne

110

Advanced Pneumatic Compression Device for Patients With Lymphedema

111

Botulinum Toxin A to Treat Painful Cutaneous Leiomyomas

112

Trends in Basal Cell Carcinoma Incidence in High-Risk Patients

113

Adverse Event Reporting in Clinical Trials of Finasteride for Alopecia

114

Education to Promote Safe Use of Isotretinoin

115

Patient-Centered, Direct-Access Online Care for AD

116

Characteristics and Associations of High-Mitotic-Rate Melanoma

117

Delivery of Compression Therapy for Venous Leg Ulcers

118

The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome

119

The Reliability of Teledermatology to Triage Inpatient Dermatology Consultations

120

Pregnancy Outcomes After Maternal Exposure to Topical Corticosteroids: A UK Population-Based Cohort Study

121

Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study

122

Sarcoidosis and Psoriasis: A Case Series and Review of the Literature Exploring Co-Incidence vs Coincidence

123

Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma: A 10-Year, Single-Institution Cohort Study

124

Hair Care Practices as a Barrier to Physical Activity in African American Women

125

Treatment of Tattoos With a Picosecond Alexandrite Laser: A Prospective Trial

126

Deferasirox for Porphyria Cutanea Tarda: A Pilot Study

127

Cutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF PathwayToxicities Associated With Vemurafenib Treatment

128

Association of Increased Dermatologist Density With Lower Melanoma Mortality

129

The Impact of Pruritus on Quality of Life: The Skin Equivalent of Pain